As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.
OKN-007
Biotech company acquires OMRF brain cancer drug
Agreement will expand clinical trials of glioblastoma drug
